---
title: Atrial Fibrillation Trial To Eliminate Risk-factors
nct_id: NCT05718336
overall_status: COMPLETED
sponsor: National Taiwan University Hospital
study_type: OBSERVATIONAL
primary_condition: Atrial Fibrillation
countries: Taiwan
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT05718336.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT05718336"
ct_last_update_post_date: 2026-01-16
last_seen_at: "2026-05-12T06:33:31.513Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Atrial Fibrillation Trial To Eliminate Risk-factors

**NCT ID:** [NCT05718336](https://clinicaltrials.gov/study/NCT05718336)

## Key Facts

- **Status:** COMPLETED
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 343
- **Lead Sponsor:** National Taiwan University Hospital
- **Conditions:** Atrial Fibrillation
- **Start Date:** 2020-05-01
- **Completion Date:** 2024-08-31
- **CT.gov Last Update:** 2026-01-16

## Brief Summary

The goal of this prospective-enrolling cohort study is to test and observe the effect of an integrated multi-discipline care program in patients with atrial fibrillation. The main questions it aims to answer are:

1. to understand the baseline characteristics and to explore the occult risk factors of the patients with AF;
2. to monitor the treatment efficacy of the patients undergoing integrated care and potentially concur the clinical obstacles that prevent the best care for patients with AF.

Participants will be treated by an integrated multi-discipline team that led by an electro-physiologist.

## Detailed Description

Atrial fibrillation (AF) is a heart condition that potentially leads to heart failure and ischemic stroke. The prevalence of AF is increasing due to aging population and improved treatment in other cardiovascular field. This study is to execute integrated multi-discipline care in a tertiary hospital, and to observe the effect and the obstacle that the program might ensue.

## Eligibility

- **Minimum age:** 18 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* At least 18 years old, who have been diagnosed with atrial fibrillation by a cardiologist with an electrocardiogram

Exclusion Criteria:

1. Unable to complete the initial assessment and cooperate with the tracker
2. Those who refuse to sign the subject's consent
```

## Interventions

- **Integrated care** (OTHER) — multi-discipline care program

## Primary Outcomes

- **AF burden** _(time frame: 0~24 months)_ — The duration in AF on 14-day ECG monitor (percent)

## Secondary Outcomes

- **MACE, major adverse cardiovascular event** _(time frame: 0~24 months)_

## Locations (1)

- National Taiwan University Hospita, Taipei, Taiwan

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.national taiwan university hospita|taipei||taiwan` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT05718336.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT05718336*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*